NTLA

Intellia Therapeutics, Inc.
NASDAQ 🏥 Healthcare In Vitro & In Vivo Diagnostic Substances SEC CIK: 0001652130

About Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc.. operates in the in vitro & in vivo diagnostic substances industry. listed on NASDAQ. headquartered in CAMBRIDGE, MA.

Company Information

Industry (SIC)
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Exchange
NASDAQ
State / Country
MA
City
CAMBRIDGE
CIK
0001652130

Related Stocks in Healthcare

QGEN
QIAGEN N.V.
NYSE
ATNM
Actinium Pharmaceuticals, Inc.
NYSE
SDEV
Stablecoin Development Corp
NYSE
PMCB
PharmaCyte Biotech, Inc.
NASDAQ
DXCM
DEXCOM INC
NASDAQ
CLRB
Cellectar Biosciences, Inc.
NASDAQ
Important Disclaimer This information is sourced from SEC filings and public data. It is for educational and informational purposes only and is NOT financial advice. Not a recommendation to buy, sell, or hold any security. Consult a qualified financial advisor before making investment decisions.